Natera (NTRA) Announces DECIPHER Phase 2 Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/28/2026

1. SPY
2. AKAM
3. COST
4. META
5. NVDA
6. ZS
7. OKTA
8. VEON
9. PRME
10. AWK

Go back to Natera (NTRA) Announces DECIPHER Phase 2 Trial
(NASDAQ: NTRA) Delayed: 412.56 --0 (-0%)
Previous Close $412.56    52 Week High $13.80 
Open $412.56    52 Week Low $6.52 
Day High $412.56    P/E N/A 
Day Low $412.56    EPS $0.00 
Volume 153